Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients

Cancer treatment with doxorubicin (DOX) can induce cumulative dose-dependent cardiotoxicity. Currently, there are no specific biomarkers that can identify patients at risk during the initial doses of chemotherapy. The aim of this study was to examine plasma cytokines/chemokines and potential cardiov...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Biol Med (Maywood)
Autors principals: Yu, Li-Rong, Cao, Zhijun, Makhoul, Issam, Daniels, Jaclyn R, Klimberg, Suzanne, Wei, Jeanne Y, Bai, Jane PF, Li, Jinong, Lathrop, Julia T, Beger, Richard D, Todorova, Valentina K
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813873/
https://ncbi.nlm.nih.gov/pubmed/29224368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217746383
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars